Sfoglia per AUTORE
HU H
Collezione AO Ordine Mauriziano

  

Items : 10

Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial. in BMC infectious diseases / BMC Infect Dis. 2022 Nov 22;22(1):879. doi: 10.1186/s12879-022-07716-5.

2022
ASL Torino 3
ASL Torino 5
AO Ordine Mauriziano
ASL Alessandria
ASL Torino 4
ASL Città di Torino
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
ASL VCO
ASL Asti
ASL Novara
ASL Cuneo 2
AOU San Luigi di Orbassano

Scozzari G; Mitola B; Benedetti V; Danielle F; Libanore V; Blangetti I; Aldieri C; Converso M; Calcagno A; Bergamo D; Berti P; Pittaluga F; Avolio M; Costa C; Raso S; Chinaglia A; Vitale F; Liccardi MM; Canta F; Russo ML; Tornello A; Maddalena L; Delios G; Baldassano S; Mattei A; De Micheli AG; Marletto FP; Russo A; Nucci A; et alii...

Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: A case report in Blood Transfusion

2013
AO Ordine Mauriziano

Tarella C; De Crescenzo A; Ricca I; Hu H; Gottardi D; Gueli A;

Frequency and clinical outcome of primary refractory disease in nonhodgkin's lymphoma: A retrospective survey on 3,492 newly diagnosed patients undergoing first-line chemotherapy in Haematologica

2013
AO Ordine Mauriziano

Tarella C; Gueli A; Delaini F; Rossi A; Barbui A; Gritti G; Caracciolo D; Hu H; Gottardi D; Passera R; Rambaldi A;

Telomere loss is an early and persistent abnormality in leukocytes from patients treated with conventional chemotherapy but not from those exposed to rituximab alone in Haematologica

2013
AO Ordine Mauriziano

Gueli A; Risso A; Spatola T; Hu H; Gottardi D; De Crescenzo A; Buttiglieri S; Tarella C;

Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: A case report in Blood Coagulation and Fibrinolysis

2012
AO Ordine Mauriziano

Wade M; Tarella C; Hu H; Gueli A; Ruella M; Sivera P;

Primary refractory disease in non-Hodgkin's lymphoma: A retrospective study on 3,952 newly diagnosed patients undergoing first-line chemotherapy in Blood

2012
AO Ordine Mauriziano

Tarella C; Gueli A; Delaini F; Rossi A; Barbui AM; Gritti G; Caracciolo D; Hu H; Gottardi D; Passera R; Rambaldi A;

Cell-therapy with HLA-mismatched mobilized peripheral blood stem cells after standard chemotherapy in elderly patients with acute myeloid leukemia: Preliminary data on feasibility and safety in Haematologica

2012
AO Ordine Mauriziano
AOU Città della Salute di Torino

Cignetti A; Ruella M; Hu H; Elia A; Tassi V; Redoglia V; Gottardi D; Tarella C;

Early and persistent telomere shortening in leukocytes from patients treated with conventional chemotherapy but not from those exposed to rituximab alone in Haematologica

2012
AO Ordine Mauriziano

Gueli A; Risso A; Ruella M; Spatola T; Hu H; Gottardi D; De Crescenzo A; Buttiglieri S; Tarella C;

Role of whole body magnetic resonance including diffusion weighted imaging in the initial staging of lymphoma in Haematologica

2012
AO Ordine Mauriziano

Tarella C; Cirillo S; Hu H; Gueli A; Ruella M; Petracchini M; Gottardi D; Lario C; De Crescenzo A; Balbo-Mussetto A; Saviolo C;

Early and permanent telomere shortening in bone marrow-derived cells following chemotherapy: A parallel study in vivo in lymphoma patients and in vitro in cultured mesenchymal stem cells in Blood

2011
AO Ordine Mauriziano

Gueli A; Ruella M; Risso A; Spatola T; Hu HJ; Gottardi D; De Crescenzo A; Buttiglieri S; Tarella C;